Cultivates cannabis plants in the United States. Manufactures a variety of cannabis products, including flower, edibles, and concentrates. Now — the numbers.
This is an established company with proven profits.
Average growth of 36% a year over the last 4 years. Red columns mark years that ended in a loss.
The gap is $4.3M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 63.6× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades 47% below its peak. The market has trimmed its expectations for the company.
Over the last 4 years, sales grew about 36% a year on average.
Over the last 12 months, company executives reported 4 buys and 1 sell. Management buying with its own money is usually read as a good sign.
The stock sits at $0.44. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The company’s market value is 64 times its annual profit. Even a small disappointment could hit the price hard.
Against everything we grade, GRUSF lands near the bottom. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: GRUSF does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.